Dimeric L-dopa derivatives as potential prodrugs. 2001

A Di Stefano, and B Mosciatti, and G M Cingolani, and G Giorgioni, and M Ricciutelli, and I Cacciatore, and P Sozio, and F Claudi
Dipartimento di Scienze del Farmaco, Università G. D'Annunzio, Chieti, Italy. adistefano@unich.it

A series of dimeric derivatives (+)-1, and (+)-2, and (+)-3a-d of L-Dopa diacetyl esters was synthesized and evaluated as potential L-Dopa prodrugs with improved physicochemical properties. All the new compounds showed chemical stability in aqueous buffer solutions (pH 1.3 and 7.4). A relatively slow release of L-Dopa in human plasma was observed.

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

A Di Stefano, and B Mosciatti, and G M Cingolani, and G Giorgioni, and M Ricciutelli, and I Cacciatore, and P Sozio, and F Claudi
December 1987, Drug design and delivery,
A Di Stefano, and B Mosciatti, and G M Cingolani, and G Giorgioni, and M Ricciutelli, and I Cacciatore, and P Sozio, and F Claudi
September 2010, European journal of medicinal chemistry,
A Di Stefano, and B Mosciatti, and G M Cingolani, and G Giorgioni, and M Ricciutelli, and I Cacciatore, and P Sozio, and F Claudi
September 2019, Bioorganic & medicinal chemistry letters,
A Di Stefano, and B Mosciatti, and G M Cingolani, and G Giorgioni, and M Ricciutelli, and I Cacciatore, and P Sozio, and F Claudi
August 1987, The Journal of pharmacy and pharmacology,
A Di Stefano, and B Mosciatti, and G M Cingolani, and G Giorgioni, and M Ricciutelli, and I Cacciatore, and P Sozio, and F Claudi
October 1987, The Journal of pharmacy and pharmacology,
A Di Stefano, and B Mosciatti, and G M Cingolani, and G Giorgioni, and M Ricciutelli, and I Cacciatore, and P Sozio, and F Claudi
June 1989, Pharmaceutical research,
A Di Stefano, and B Mosciatti, and G M Cingolani, and G Giorgioni, and M Ricciutelli, and I Cacciatore, and P Sozio, and F Claudi
January 2003, Journal of drug targeting,
A Di Stefano, and B Mosciatti, and G M Cingolani, and G Giorgioni, and M Ricciutelli, and I Cacciatore, and P Sozio, and F Claudi
March 2010, Bioorganic & medicinal chemistry,
A Di Stefano, and B Mosciatti, and G M Cingolani, and G Giorgioni, and M Ricciutelli, and I Cacciatore, and P Sozio, and F Claudi
April 1986, Biochemical Society transactions,
A Di Stefano, and B Mosciatti, and G M Cingolani, and G Giorgioni, and M Ricciutelli, and I Cacciatore, and P Sozio, and F Claudi
July 2008, Archiv der Pharmazie,
Copied contents to your clipboard!